Purchases and Sales Made in Q3 2022 in Altimmune, Inc. (ALT)
This table provides information about the institutional ownership of Altimmune, Inc. (ALT) during Q3 2022. The information is specifically focused on institutions that hold shares of Altimmune, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-425K- 47.4% |
$4.54M - $9.53M
|
472K
$3.36M
|
|
|
Nov 10, 2022
Q3 2022
|
Citigroup Inc
|
SELL
|
- |
-617K- 69.41% |
$6.59M - $13.8M
|
272K
$1.93M
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-782K- 56.92% |
$8.35M - $17.5M
|
592K
$4.21M
|
|
|
Nov 14, 2022
Q3 2022
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-793K- 56.9% |
$8.46M - $17.8M
|
600K
$4.27M
|
|
|
Nov 03, 2022
Q3 2022
|
Barclays PLC
London, X0 |
SELL
|
- |
-878K- 82.36% |
$9.36M - $19.7M
|
188K
$1.34M
|
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.02M- 88.74% |
$10.9M - $22.8M
|
129K
$919K
|